• O NAMA

Welcome

Forgot password?

Not a member? Join today

Logo
  • Početna
  • Bolesti
    • Hronična limfocitna leukemija
    • Non hočkinski limfom
    • Hočkinski limfom
    • Leukemije
      • AML
      • ALL
  • Edukacija
    • Prezentacije
      • HLL
      • NHL
      • HL
    • Kvizovi
      • HLL
      • NHL
      • HL
  • Stil života
    • Zdraviji recepti
    • Fizička aktivnost
    • Prevencija
    • Korisni saveti
  • Resursi
    • Video
    • Brošure
    • Infografike
  • Blog
  • English
  • Početna
  • Bolesti
    • Hronična limfocitna leukemija
    • Non hočkinski limfom
    • Hočkinski limfom
    • Leukemije
      • AML
      • ALL
  • Edukacija
    • Prezentacije
      • HLL
      • NHL
      • HL
    • Kvizovi
      • HLL
      • NHL
      • HL
  • Stil života
    • Zdraviji recepti
    • Fizička aktivnost
    • Prevencija
    • Korisni saveti
  • Resursi
    • Video
    • Brošure
    • Infografike
  • Blog
  • English

Diffuse large B-cell lymphoma: 10 years’ real-world clinical experience with rituximab plus cyclophosphamide, doxorubicin, vincristine and prednisolone

13 Apr 2018
  • maja
  • Nehočkinski limfom

Diffuse large B-cell lymphoma: 10 years’ real-world clinical experience with rituximab plus cyclophosphamide, doxorubicin, vincristine and prednisolone

Diffuse large B-cell lymphoma: 10 years’ real-world clinical experience with rituximab plus cyclophosphamide, doxorubicin, vincristine and

Read More

13 Apr 2018
  • maja
  • Hočkinov limfom, Hronična limfocitna leukemija, Nehočkinski limfom

NIH study revises molecular classification for most common type of lymphoma

NIH study revises molecular classification for the most common type of lymphoma   Subgroups of DLBCL by gene expression (left) defined

Read More

Izradu platforme podržala kompanija

KONTAKT

Udruženje LIPA
+ 381 60 0 222 317
majaklipa@gmail.com
www.lipa.org.rs

Budite u toku sa najnovijim dešavanjima. Prijavite se

© Copyright LIPA 2017